Media coverage:

Proactive – Exosome tech delivers therapeutic proteins to hard to access region of brain

11 October 2021: ReNeuron Group’s Olav Hellebo joins Proactive to talk about their exosome technology which has shown it can deliver therapeutic proteins to a hard to access region of the human brain.

Share Talk – interview with Olav Hellebo

6 April 2021: Please click here to access the Share Talk website to hear the interview with Olav Hellebo, SEO of ReNeuron.

February 2021 – OHSU Research News: OHSU Casey Eye Institute grows gene and cell therapy research by performing its first stem cell therapy in the retina

To read the full article please click here.

January 2021 – Proactive Investors: ReNeuron Group completes first dosing of patients in study for new degenerative eye disease therapy

https://youtu.be/EGhy9OF6HM0

July 2020 – Proactive Investors: ReNeuron’s Michael Hunt says key focus now is to build dataset for retinal disease study
June 2020 – Proactive Investors: ReNeuron’s Michael Hunt explains new emphasis on its retinal and exosome technology programmes

https://youtu.be/DxPq6_WZ-6U

May 2020 – Proactive Investors: ReNeuron’s Michael Hunt talks new potential for its CTX therapy in treating Huntington’s disease

https://youtu.be/dM49NSi-ZqM

April 2020 – Proactive Investors: ReNeuron looking at applications of its own technology to deliver virus vaccine
February 2020 – Proactive Investors: ReNeuron’s retinal treatment ‘appears to have sustained long-term beneficial effect’

https://youtu.be/EGrLvQrwWs4

December 2019 – Proactive Investors: ReNeuron in active on-going talks for further potential out-licence deals

https://youtu.be/sROQ-Ubn4sA

Section: News

Filter by: